Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

被引:1437
作者
Park, Eek Joong [1 ,2 ]
Lee, Jun Hee [1 ,2 ]
Yu, Guann-Yi [1 ,2 ]
He, Guobin [1 ,2 ]
Ali, Syed Raza [1 ,2 ]
Holzer, Ryan G. [1 ,2 ]
Oesterreicher, Christoph H. [1 ,2 ,3 ]
Takahashi, Hiroyuki [1 ,2 ]
Karin, Michael [1 ,2 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA
基金
加拿大自然科学与工程研究理事会; 英国惠康基金;
关键词
INDUCED INSULIN-RESISTANCE; SUBCUTANEOUS ADIPOSE-TISSUE; HEPATOCELLULAR-CARCINOMA; KAPPA-B; CHEMICAL HEPATOCARCINOGENESIS; COMPENSATORY PROLIFERATION; CANCER DEVELOPMENT; INTERLEUKIN-6; CELLS; SERUM;
D O I
10.1016/j.cell.2009.12.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epidemiological studies indicate that overweight and obesity are associated with increased cancer risk. To study how obesity augments cancer risk and development, we focused on hepatocellular carcinoma (HCC), the common form of liver cancer whose occurrence and progression are the most strongly affected by obesity among all cancers. We now demonstrate that either dietary or genetic obesity is a potent bona fide liver tumor promoter in mice. Obesity-promoted HCC development was dependent on enhanced production of the tumor-promoting cytokines IL-6 and TNF, which cause hepatic inflammation and activation of the oncogenic transcription factor STAT3. The chronic inflammatory response caused by obesity and enhanced production of IL-6 and TNF may also increase the risk of other cancers.
引用
收藏
页码:197 / 208
页数:12
相关论文
共 53 条
[31]   Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo [J].
Mohamed-Ali, V ;
Goodrick, S ;
Rawesh, A ;
Katz, DR ;
Miles, JM ;
Yudkin, JS ;
Klein, S ;
Coppack, SW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4196-4200
[32]   Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences [J].
Nakagawa, Hayato ;
Maeda, Shin ;
Yoshida, Haruhiko ;
Tateishi, Ryosuke ;
Masuzaki, Ryota ;
Ohki, Takamasa ;
Hayakawa, Yoku ;
Kinoshita, Hiroto ;
Yamakado, Minoru ;
Kato, Naoya ;
Shiina, Shuichiro ;
Omata, Masao .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (10) :2264-2269
[33]   Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production [J].
Naugler, Willscott E. ;
Sakurai, Toshiharu ;
Kim, Sunhwa ;
Maeda, Shin ;
Kim, KyoungHyun ;
Elsharkawy, Ahmed M. ;
Karin, Michael .
SCIENCE, 2007, 317 (5834) :121-124
[34]   INTERLEUKIN-6 STIMULATES HEPATIC TRIGLYCERIDE SECRETION IN RATS [J].
NONOGAKI, K ;
FULLER, GM ;
FUENTES, NL ;
MOSER, AH ;
STAPRANS, I ;
GRUNFELD, C ;
FEINGOLD, KR .
ENDOCRINOLOGY, 1995, 136 (05) :2143-2149
[35]   Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease [J].
Parekh, Samir ;
Anania, Frank A. .
GASTROENTEROLOGY, 2007, 132 (06) :2191-2207
[36]   EFFECTS OF THE OBESE GENE-PRODUCT ON BODY-WEIGHT REGULATION IN OB/OB MICE [J].
PELLEYMOUNTER, MA ;
CULLEN, MJ ;
BAKER, MB ;
HECHT, R ;
WINTERS, D ;
BOONE, T ;
COLLINS, F .
SCIENCE, 1995, 269 (5223) :540-543
[37]   Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours [J].
Rebouissou, Sandra ;
Amessou, Mohamed ;
Couchy, Gabrielle ;
Poussin, Karine ;
Imbeaud, Sandrine ;
Pilati, Camilla ;
Izard, Tina ;
Balabaud, Charles ;
Bioulac-Sage, Paulette ;
Zucman-Rossi, Jessica .
NATURE, 2009, 457 (7226) :200-U96
[38]   Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis [J].
Sakurai, Toshiharu ;
He, Guobin ;
Matsuzawa, Atsushi ;
Yu, Guann-Yi ;
Maeda, Shin ;
Hardiman, Gary ;
Karin, Michael .
CANCER CELL, 2008, 14 (02) :156-165
[39]   Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation [J].
Sakurai, Toshiharu ;
Maeda, Shin ;
Chang, Lufen ;
Karin, Michael .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (28) :10544-10551
[40]   Cancer and phase II drug-metabolizing enzymes [J].
Sheweita, SA ;
Tilmisany, AK .
CURRENT DRUG METABOLISM, 2003, 4 (01) :45-58